Cargando…

Is the Relationship between Prenatal Exposure to PCB-153 and Decreased Birth Weight Attributable to Pharmacokinetics?

Background: A recent meta-analysis based on data from > 7,000 pregnancies reported an association between prenatal polychlorinated biphenyl (PCB)–153 exposure and reduced birth weight. Gestational weight gain, which is associated negatively with PCB levels in maternal and cord blood, and positive...

Descripción completa

Detalles Bibliográficos
Autores principales: Verner, Marc-André, McDougall, Robin, Glynn, Anders, Andersen, Melvin E., Clewell, Harvey J., Longnecker, Matthew P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Institute of Environmental Health Sciences 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3801461/
https://www.ncbi.nlm.nih.gov/pubmed/23934733
http://dx.doi.org/10.1289/ehp.1206457
_version_ 1782288090144964608
author Verner, Marc-André
McDougall, Robin
Glynn, Anders
Andersen, Melvin E.
Clewell, Harvey J.
Longnecker, Matthew P.
author_facet Verner, Marc-André
McDougall, Robin
Glynn, Anders
Andersen, Melvin E.
Clewell, Harvey J.
Longnecker, Matthew P.
author_sort Verner, Marc-André
collection PubMed
description Background: A recent meta-analysis based on data from > 7,000 pregnancies reported an association between prenatal polychlorinated biphenyl (PCB)–153 exposure and reduced birth weight. Gestational weight gain, which is associated negatively with PCB levels in maternal and cord blood, and positively with birth weight, could substantially confound this association. Objective: We sought to estimate the influence of gestational weight gain on the association between PCB-153 exposure and birth weight using a pharmacokinetic model. Methods: We modified a recently published pharmacokinetic model and ran Monte Carlo simulations accounting for variability in physiologic parameters and their correlations. We evaluated the pharmacokinetic model by comparing simulated plasma PCB-153 levels during pregnancy to serial measurements in 10 pregnant women from another study population. We estimated the association between simulated plasma PCB-153 levels and birth weight using linear regression models. Results: The plasma PCB-153 level profiles generated with the pharmacokinetic model were comparable to measured levels in 10 pregnant women. We estimated a 118-g decrease in birth weight (95% CI: –129, –106 g) for each 1-μg/L increase in simulated cord plasma PCB-153, compared with the 150-g decrease estimated based on the previous meta-analysis. The estimated decrease in birth weight was reduced to –6 g (95% CI: –18, 6 g) when adjusted for simulated gestational weight gain. Conclusion: Our findings suggest that associations previously noted between PCB levels and birth weight may be attributable to confounding by maternal weight gain during pregnancy. Citation: Verner MA, McDougall R, Glynn A, Andersen ME, Clewell HJ III, Longnecker MP. 2013. Is the relationship between prenatal exposure to PCB-153 and decreased birth weight attributable to pharmacokinetics? Environ Health Perspect 121:1219–1224; http://dx.doi.org/10.1289/ehp.1206457
format Online
Article
Text
id pubmed-3801461
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher National Institute of Environmental Health Sciences
record_format MEDLINE/PubMed
spelling pubmed-38014612013-10-22 Is the Relationship between Prenatal Exposure to PCB-153 and Decreased Birth Weight Attributable to Pharmacokinetics? Verner, Marc-André McDougall, Robin Glynn, Anders Andersen, Melvin E. Clewell, Harvey J. Longnecker, Matthew P. Environ Health Perspect Research Background: A recent meta-analysis based on data from > 7,000 pregnancies reported an association between prenatal polychlorinated biphenyl (PCB)–153 exposure and reduced birth weight. Gestational weight gain, which is associated negatively with PCB levels in maternal and cord blood, and positively with birth weight, could substantially confound this association. Objective: We sought to estimate the influence of gestational weight gain on the association between PCB-153 exposure and birth weight using a pharmacokinetic model. Methods: We modified a recently published pharmacokinetic model and ran Monte Carlo simulations accounting for variability in physiologic parameters and their correlations. We evaluated the pharmacokinetic model by comparing simulated plasma PCB-153 levels during pregnancy to serial measurements in 10 pregnant women from another study population. We estimated the association between simulated plasma PCB-153 levels and birth weight using linear regression models. Results: The plasma PCB-153 level profiles generated with the pharmacokinetic model were comparable to measured levels in 10 pregnant women. We estimated a 118-g decrease in birth weight (95% CI: –129, –106 g) for each 1-μg/L increase in simulated cord plasma PCB-153, compared with the 150-g decrease estimated based on the previous meta-analysis. The estimated decrease in birth weight was reduced to –6 g (95% CI: –18, 6 g) when adjusted for simulated gestational weight gain. Conclusion: Our findings suggest that associations previously noted between PCB levels and birth weight may be attributable to confounding by maternal weight gain during pregnancy. Citation: Verner MA, McDougall R, Glynn A, Andersen ME, Clewell HJ III, Longnecker MP. 2013. Is the relationship between prenatal exposure to PCB-153 and decreased birth weight attributable to pharmacokinetics? Environ Health Perspect 121:1219–1224; http://dx.doi.org/10.1289/ehp.1206457 National Institute of Environmental Health Sciences 2013-08-09 2013-10-01 /pmc/articles/PMC3801461/ /pubmed/23934733 http://dx.doi.org/10.1289/ehp.1206457 Text en http://creativecommons.org/publicdomain/mark/1.0/ Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, ?Reproduced with permission from Environmental Health Perspectives?); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright.
spellingShingle Research
Verner, Marc-André
McDougall, Robin
Glynn, Anders
Andersen, Melvin E.
Clewell, Harvey J.
Longnecker, Matthew P.
Is the Relationship between Prenatal Exposure to PCB-153 and Decreased Birth Weight Attributable to Pharmacokinetics?
title Is the Relationship between Prenatal Exposure to PCB-153 and Decreased Birth Weight Attributable to Pharmacokinetics?
title_full Is the Relationship between Prenatal Exposure to PCB-153 and Decreased Birth Weight Attributable to Pharmacokinetics?
title_fullStr Is the Relationship between Prenatal Exposure to PCB-153 and Decreased Birth Weight Attributable to Pharmacokinetics?
title_full_unstemmed Is the Relationship between Prenatal Exposure to PCB-153 and Decreased Birth Weight Attributable to Pharmacokinetics?
title_short Is the Relationship between Prenatal Exposure to PCB-153 and Decreased Birth Weight Attributable to Pharmacokinetics?
title_sort is the relationship between prenatal exposure to pcb-153 and decreased birth weight attributable to pharmacokinetics?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3801461/
https://www.ncbi.nlm.nih.gov/pubmed/23934733
http://dx.doi.org/10.1289/ehp.1206457
work_keys_str_mv AT vernermarcandre istherelationshipbetweenprenatalexposuretopcb153anddecreasedbirthweightattributabletopharmacokinetics
AT mcdougallrobin istherelationshipbetweenprenatalexposuretopcb153anddecreasedbirthweightattributabletopharmacokinetics
AT glynnanders istherelationshipbetweenprenatalexposuretopcb153anddecreasedbirthweightattributabletopharmacokinetics
AT andersenmelvine istherelationshipbetweenprenatalexposuretopcb153anddecreasedbirthweightattributabletopharmacokinetics
AT clewellharveyj istherelationshipbetweenprenatalexposuretopcb153anddecreasedbirthweightattributabletopharmacokinetics
AT longneckermatthewp istherelationshipbetweenprenatalexposuretopcb153anddecreasedbirthweightattributabletopharmacokinetics